Oncology Central

Grading neuroendocrine tumors: are we there?


Grading neoplasms is meant to associate morphology to increased death risk. This is the core of histopathology work and demands well-defined and reproducible histopathological criteria, together with stringent clinical observation. The rule says the higher the grade the worse the prognosis. This is likely the simplest method to associate tumor biology as depicted by morphology – the face of cancer – to clinical behavior.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.